Juniper Pharmaceuticals, Inc. Debt to Equity Ratio 2010-2018 | JNP
Current and historical debt to equity ratio values for Juniper Pharmaceuticals, Inc. (JNP) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Juniper Pharmaceuticals, Inc. debt/equity for the three months ending June 30, 2018 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2018-06-30 | $0.02B | $0.05B | 0.40 |
| 2018-03-31 | $0.01B | $0.05B | 0.27 |
| 2017-12-31 | $0.02B | $0.04B | 0.48 |
| 2017-09-30 | $0.02B | $0.04B | 0.55 |
| 2017-06-30 | $0.02B | $0.04B | 0.49 |
| 2017-03-31 | $0.02B | $0.04B | 0.44 |
| 2016-12-31 | $0.02B | $0.04B | 0.43 |
| 2016-09-30 | $0.02B | $0.03B | 0.57 |
| 2016-06-30 | $0.02B | $0.03B | 0.52 |
| 2016-03-31 | $0.02B | $0.04B | 0.46 |
| 2015-12-31 | $0.01B | $0.04B | 0.37 |
| 2015-09-30 | $0.01B | $0.04B | 0.32 |
| 2015-06-30 | $0.01B | $0.04B | 0.30 |
| 2015-03-31 | $0.01B | $0.04B | 0.25 |
| 2014-12-31 | $0.01B | $0.04B | 0.38 |
| 2014-09-30 | $0.01B | $0.04B | 0.24 |
| 2014-06-30 | $0.01B | $0.04B | 0.31 |
| 2014-03-31 | $0.01B | $0.04B | 0.30 |
| 2013-12-31 | $0.01B | $0.05B | 0.27 |
| 2013-09-30 | $0.01B | $0.05B | 0.29 |
| 2013-06-30 | $0.00B | $0.04B | 0.13 |
| 2013-03-31 | $0.00B | $0.03B | 0.12 |
| 2012-12-31 | $0.01B | $0.03B | 0.16 |
| 2012-09-30 | $0.01B | $0.03B | 0.28 |
| 2012-06-30 | $0.01B | $0.03B | 0.22 |
| 2012-03-31 | $0.01B | $0.03B | 0.29 |
| 2011-12-31 | $0.02B | $0.02B | 0.70 |
| 2011-09-30 | $0.01B | $0.02B | 0.57 |
| 2011-06-30 | $0.02B | $0.02B | 1.02 |
| 2011-03-31 | $0.03B | $-0.00B | -14.80 |
| 2010-12-31 | $0.05B | $-0.02B | -2.50 |
| 2010-09-30 | $0.04B | $-0.01B | -3.52 |
| 2010-06-30 | $0.08B | $-0.03B | -2.73 |
| 2010-03-31 | $0.06B | $-0.02B | -2.68 |
| 2009-12-31 | $0.06B | $-0.02B | -3.54 |
| 2009-09-30 | $0.06B | $-0.02B | -2.92 |
| 2009-06-30 | $0.05B | $-0.01B | -3.83 |
| 2009-03-31 | $0.05B | $-0.01B | -5.63 |
